{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:27:19Z","timestamp":1772897239952,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["23PRE1019204"],"award-info":[{"award-number":["23PRE1019204"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018136","name":"Murray State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM115459"],"award-info":[{"award-number":["R01GM115459"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.molpha.2025.100070","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T06:39:28Z","timestamp":1754635168000},"page":"100070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pirin does not bind to p65 or regulate NF\u03baB-dependent gene expression but does modulate cellular quercetin levels"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6232-3505","authenticated-orcid":false,"given":"Melissa","family":"Meschkewitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika M.","family":"Lisabeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denaly Anna","family":"Cab Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Leipprandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0501-0008","authenticated-orcid":false,"given":"Richard R.","family":"Neubig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.molpha.2025.100070_bib1","doi-asserted-by":"crossref","first-page":"8482","DOI":"10.1074\/jbc.272.13.8482","article-title":"Identification of pirin, a novel highly conserved nuclear protein","volume":"272","author":"Wendler","year":"1997","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.molpha.2025.100070_bib2","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1074\/jbc.M310022200","article-title":"Crystal structure of human pirin: an iron-binding nuclear protein and transcription cofactor","volume":"279","author":"Pang","year":"2004","journal-title":"J Biol Chem"},{"issue":"31","key":"10.1016\/j.molpha.2025.100070_bib3","doi-asserted-by":"crossref","first-page":"28675","DOI":"10.1074\/jbc.M501034200","article-title":"Structural and biochemical analysis reveal pirins to possess quercetinase activity","volume":"280","author":"Adams","year":"2005","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.molpha.2025.100070_bib4","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1021\/acschembio.9b00575","article-title":"Structure-dependent modulation of substrate binding and biodegradation activity of pirin proteins toward plant flavonols","volume":"14","author":"Guo","year":"2019","journal-title":"ACS Chem Biol"},{"issue":"2","key":"10.1016\/j.molpha.2025.100070_bib5","first-page":"116","article-title":"Role of pirin, an oxidative stress sensor protein, in epithelial carcinogenesis","volume":"10","author":"Perez-Dominguez","year":"2021","journal-title":"Biology (Basel)"},{"issue":"2","key":"10.1016\/j.molpha.2025.100070_bib6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/1878-0261.12405","article-title":"Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p","volume":"13","author":"Arai","year":"2019","journal-title":"Mol Oncol"},{"issue":"2","key":"10.1016\/j.molpha.2025.100070_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/pros.22729","article-title":"Pirin down-regulates the EAF2\/U19 protein and alleviates its growth inhibition in prostate cancer cells","volume":"74","author":"Qiao","year":"2014","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.molpha.2025.100070_bib8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1536\/ihj.24-002","article-title":"PLIN5 suppresses lipotoxicity and ferroptosis in cardiomyocyte via modulating PIR\/NF-\u03baB axis","volume":"65","author":"Shen","year":"2024","journal-title":"Int Heart J"},{"key":"10.1016\/j.molpha.2025.100070_bib9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbrc.2020.12.066","article-title":"Pirin is a nuclear redox-sensitive modulator of autophagy-dependent ferroptosis","volume":"536","author":"Hu","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"issue":"1-2","key":"10.1016\/j.molpha.2025.100070_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11010-013-1931-0","article-title":"Basal PIR expression in HeLa cells is driven by NRF2 via evolutionary conserved antioxidant response element","volume":"389","author":"Brz\u00f3ska","year":"2014","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"10.1016\/j.molpha.2025.100070_bib11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/antiox11020262","article-title":"Pirin, an Nrf2-regulated protein, is overexpressed in human colorectal tumors","volume":"11","author":"Zhang","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"24","key":"10.1016\/j.molpha.2025.100070_bib12","doi-asserted-by":"crossref","first-page":"9722","DOI":"10.1073\/pnas.1221743110","article-title":"Pirin is an iron-dependent redox regulator of NF-\u03baB","volume":"110","author":"Liu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"37","key":"10.1016\/j.molpha.2025.100070_bib13","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1021\/acs.biochem.7b00528","article-title":"Redox-specific allosteric modulation of the conformational dynamics of \u03bab DNA by pirin in the NF-\u03baB supramolecular complex","volume":"56","author":"Adeniran","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.molpha.2025.100070_bib14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ymben.2018.06.008","article-title":"Pirin: a novel redox-sensitive modulator of primary and secondary metabolism in Streptomyces","volume":"48","author":"Tal\u00e0","year":"2018","journal-title":"Metab Eng"},{"issue":"7","key":"10.1016\/j.molpha.2025.100070_bib15","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.3390\/cancers12071904","article-title":"Human papillomavirus 16 E7 promotes EGFR\/PI3K\/AKT1\/NRF2 signaling pathway contributing to PIR\/NF-\u03baB activation in oral cancer cells","volume":"12","author":"Carrillo-Beltr\u00e1n","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.molpha.2025.100070_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0289158","article-title":"Role of the redox state of the Pirin-bound cofactor on interaction with the master regulators of inflammation and other pathways","volume":"18","author":"Ahsan","year":"2023","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.molpha.2025.100070_bib17","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1038\/sj.onc.1202717","article-title":"The Bcl-3 oncoprotein acts as a bridging factor between NF-\u03baB\/Rel and nuclear co-regulators","volume":"18","author":"Dechend","year":"1999","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.molpha.2025.100070_bib18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1021\/acsptsci.8b00048","article-title":"Identification of pirin as a molecular target of the CCG-1423\/CCG-203971 series of antifibrotic and antimetastatic compounds","volume":"2","author":"Lisabeth","year":"2019","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"10.1016\/j.molpha.2025.100070_bib19","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41598-017-00212-w","article-title":"Local delivery of novel MRTF\/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis","volume":"7","author":"Yu-Wai-Man","year":"2017","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.molpha.2025.100070_bib20","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.bmcl.2017.02.070","article-title":"Pharmacokinetic optimitzation of CCG-203971: novel inhibitors of the Rho\/MRTF\/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma","volume":"27","author":"Hutchings","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"10.1016\/j.molpha.2025.100070_bib21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1124\/jpet.114.213520","article-title":"Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor\/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury","volume":"349","author":"Haak","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.molpha.2025.100070_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1158\/1535-7163.MCT-16-0482","article-title":"Pharmacological inhibition of myocardin-related transcription factor pathway blocks lung metastases of RhoC-overexpressing melanoma","volume":"16","author":"Haak","year":"2017","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"10.1016\/j.molpha.2025.100070_bib23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ccell.2019.05.015","article-title":"RAC1P29S induces a mesenchymal phenotypic switch via serum response factor to promote melanoma development and therapy resistance","volume":"36","author":"Lionarons","year":"2019","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.molpha.2025.100070_bib24","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/s41388-019-1074-1","article-title":"Rho-mediated signaling promotes BRAF inhibitor resistance in de-differentiated melanoma cells","volume":"39","author":"Misek","year":"2020","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.molpha.2025.100070_bib25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nchembio.423","article-title":"A small-molecule inhibitor shows that pirin regulates migration of melanoma cells","volume":"6","author":"Miyazaki","year":"2010","journal-title":"Nat Chem Biol"},{"issue":"1","key":"10.1016\/j.molpha.2025.100070_bib26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1021\/acs.jmedchem.6b01055","article-title":"Discovery of a chemical probe bisamide (CCT251236): an orally bioavailable efficacious pirin ligand from a heat shock transcription factor 1 (HSF1) phenotypic screen","volume":"60","author":"Cheeseman","year":"2017","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.molpha.2025.100070_bib27","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4161\/cc.8.3.7701","article-title":"Single-vector inducible lentiviral RNAi system for oncology target validation","volume":"8","author":"Wiederschain","year":"2009","journal-title":"Cell Cycle"},{"issue":"18","key":"10.1016\/j.molpha.2025.100070_bib28","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.908","article-title":"Isolation of mouse embryo fibroblasts","volume":"3","author":"Durkin","year":"2013","journal-title":"Bio Protoc"},{"issue":"2","key":"10.1016\/j.molpha.2025.100070_bib29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1124\/jpet.119.261347","article-title":"Direct measurement of kinetic parameters of ABCG2-dependent transport of natural flavonoids using a fluorogenic substrate","volume":"371","author":"Rozanski","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.molpha.2025.100070_bib30","article-title":"Pirin inhibits FAS-mediated apoptosis to support colorectal cancer survival","volume":"11","author":"Ma","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.molpha.2025.100070_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2121-11-5","article-title":"Pirin delocalization in melanoma progression identified by high content immuno-detection based approaches","volume":"11","author":"Licciulli","year":"2010","journal-title":"BMC Cell Biol"},{"issue":"2","key":"10.1016\/j.molpha.2025.100070_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/molpharm.120.000019","article-title":"Transforming growth factor \u03b21 increases expression of contractile genes in human pulmonary arterial smooth muscle cells by potentiating sphingosine-1-phosphate signaling","volume":"100","author":"Ji","year":"2021","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.molpha.2025.100070_bib33","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10.1016\/j.molpha.2025.100070_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.smim.2014.05.004","article-title":"Regulation of NF-\u03baB by TNF family cytokines","volume":"26","author":"Hayden","year":"2014","journal-title":"Semin Immunol"},{"issue":"6","key":"10.1016\/j.molpha.2025.100070_bib35","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1074\/jbc.273.6.3285","article-title":"p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-\u03baB p65 transactivation mediated by tumor necrosis factor","volume":"273","author":"Vanden Berghe","year":"1998","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.molpha.2025.100070_bib36","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3390\/molecules27030719","article-title":"Flavanols from nature: a phytochemistry and biological activity review","volume":"27","author":"Luo","year":"2022","journal-title":"Molecules"},{"issue":"20","key":"10.1016\/j.molpha.2025.100070_bib37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/0973-7847.194044","article-title":"Overviews of biological importance of quercetin: a bioactive flavonoid","volume":"10","author":"Anand David","year":"2016","journal-title":"Pharmacogn Rev"},{"issue":"27","key":"10.1016\/j.molpha.2025.100070_bib38","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.2174\/0115680266330678240821060623","article-title":"Therapeutic potential of quercetin in diabetic neuropathy and retinopathy: exploring molecular mechanisms","volume":"24","author":"Saikia","year":"2024","journal-title":"Curr Top Med Chem"},{"issue":"3","key":"10.1016\/j.molpha.2025.100070_bib39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11914-024-00868-0","article-title":"Quercetin in osteoporosis treatment: a comprehensive review of its mechanisms and therapeutic potential","volume":"22","author":"Feng","year":"2024","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"10.1016\/j.molpha.2025.100070_bib40","first-page":"1414","article-title":"Therapeutic potential of quercetin as an antioxidant for bone-muscle-tendon regeneration and aging","volume":"16","author":"Kim","year":"2024","journal-title":"Aging Dis"},{"issue":"3","key":"10.1016\/j.molpha.2025.100070_bib41","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1089\/ars.2014.5851","article-title":"Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease","volume":"21","author":"Cao","year":"2014","journal-title":"Antioxid Redox Signal"},{"issue":"18","key":"10.1016\/j.molpha.2025.100070_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813785","article-title":"Role of rho\/MRTF in aggressive vemurafenib-resistant murine melanomas and immune checkpoint upregulation","volume":"24","author":"Foda","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.molpha.2025.100070_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/microarrays5020013","article-title":"Small-molecule inhibition of Rho\/MKL\/SRF transcription in prostate cancer cells: modulation of cell cycle, ER stress, and metastasis gene networks","volume":"5","author":"Evelyn","year":"2016","journal-title":"Microarrays (Basel)"},{"issue":"3","key":"10.1016\/j.molpha.2025.100070_bib44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1165\/rcmb.2008-0288OC","article-title":"Critical role of serum response factor in pulmonary myofibroblast differentiation induced by TGF-\u03b2","volume":"41","author":"Sandbo","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.molpha.2025.100070_bib45","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1152\/ajprenal.00460.2018","article-title":"A conditionally immortalized Gli1-positive kidney mesenchymal cell line models myofibroblast transition","volume":"316","author":"\u00d3 hAinmhire","year":"2019","journal-title":"Am J Physiol Ren Physiol"},{"issue":"1","key":"10.1016\/j.molpha.2025.100070_bib46","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1038\/s41598-019-40764-7","article-title":"Profibrotic epithelial phenotype: a central role for MRTF and TAZ","volume":"9","author":"Bialik","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.molpha.2025.100070_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/cai2.99","article-title":"Targeting colorectal cancer using dietary flavonols","volume":"3","author":"Dubey","year":"2024","journal-title":"Cancer Innov"},{"issue":"9","key":"10.1016\/j.molpha.2025.100070_bib48","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1080\/10408398.2023.2299329","article-title":"A critical examination of human data for the biological activity of quercetin and its phase-2 conjugates","volume":"65","author":"Williamson","year":"2025","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"7","key":"10.1016\/j.molpha.2025.100070_bib49","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/ph16071020","article-title":"Recent advances in potential health benefits of quercetin","volume":"16","author":"Aghababaei","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"10.1016\/j.molpha.2025.100070_bib50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00394-002-0377-z","article-title":"Fasting plasma concentrations of selected flavonoids as markers of their ordinary dietary intake","volume":"41","author":"Radtke","year":"2002","journal-title":"Eur J Nutr"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X25153303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X25153303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:53:43Z","timestamp":1772826823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X25153303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0026895X25153303"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2025.100070","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.12.03.626411","asserted-by":"object"}]},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pirin does not bind to p65 or regulate NF\u03baB-dependent gene expression but does modulate cellular quercetin levels","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2025.100070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100070"}}